Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK

Authors:

Hollier-Hann A, Curry A, Onishchenko K, Akehurst R, Ahmed F, Davies B and Keyzor I

Publication type:

Journal article

Publication name:

Journal of Medical Economics

Citation:

Hollier-Hann A, Curry A, Onishchenko K, Akehurst R, Ahmed F, Davies B and Keyzor I.
Updated cost-effectiveness analysis of onabotulinumtoxinA for the prevention of headache in adults with chronic migraine who have previously received three or more preventive treatments in the UK. J Med Econ. 2019; 1369-6998.

Link to publication ⟶

⟵ Back to Search Results